top of page
shutterstock_670222087.jpg
Original on Transparent.png

&

Untitled design (1).png
Moringa Acquisition Corp (NASDAQ: MACA) announced a business combination with Silexion Ltd.

Silexion Therapeutics is a pioneering clinical stage, oncology-focused biotechnology company dedicated to the development of innovative treatments for unsatisfactorily treated solid tumor cancers which have the mutated KRAS oncogene.

 TEAM

1516237206806.jpg

DAN YALON

Advisor

  • 20 years of executive experience at leading Israeli high-tech companies

  • Currently CBO at SimilarWeb, and previously EVP of Products at Stratasys (NASDAQ:SSYS), CSO at NICE Systems (NASDAQ: NICE), and Head of Strategy and New Business Initiatives at Amdocs (NASDAQ: DOX) 

Ilan-483.1.jpg

ILAN LEVIN

Chairman and Chief Executive Officer

  • 25 years of executive, venture capital, and private equity experience in Israel based high-tech

  • Former board member and CEO of Stratasys (NASDAQ: SSYS), a pioneer and global leader in 3D printing

  • LinkedIn
WhatsApp Image 2022-06-09 at 2.21.38 PM (1).jpeg

GIL MAMAN

Chief Financial Officer

  • 15 years of management, M&A, and JV experience particularly within the high-tech industry

  • Served in corporate development, strategy, and operational roles with MakerBot (COO), SimilarWeb, and Stratasys

  • Previously a strategy consultant with PwC

  • LinkedIn
Tall Buildings

CONTACT US

Thanks for submitting!

Inquire at:

gil@moringaac.com

bottom of page